Ironwood Pharmaceuticals (IRWD) Total Debt Growth (1y) (2014 - 2026)
Ironwood Pharmaceuticals (IRWD) Total Debt Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.46 Bn | 87.60 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 32.62 Bn | 30.68 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.47 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | -13.33% |
| 10 | Ironwood Pharmaceuticals | 642.61 Mn | 422.14 Mn | - | 51.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.91% |
| Dec 31, 2025 | 51.86% |
| Sep 30, 2025 | 46.13% |
| Jun 30, 2025 | 37.49% |
| Mar 31, 2025 | -18.91% |
| Dec 31, 2024 | -22.93% |
| Sep 30, 2024 | -23.71% |
| Jun 30, 2024 | -29.06% |
| Jun 30, 2019 | -36.34% |
| Mar 31, 2019 | -33.51% |
| Dec 31, 2018 | -31.64% |
| Sep 30, 2018 | -55.83% |
| Jun 30, 2018 | -23.72% |
| Mar 31, 2018 | -15.58% |
| Dec 31, 2017 | 0.45% |
| Sep 30, 2017 | 67.91% |
| Jun 30, 2017 | 43.33% |
| Mar 31, 2017 | 28.82% |
| Dec 31, 2016 | 10.17% |
| Sep 30, 2016 | 3.34% |